We are live on ! Find out more
ISEE

IVERIC bio

Delisted

ISEE was delisted on the 10th of July, 2023.

71 hedge funds and large institutions have $58.3M invested in IVERIC bio in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $129K | Put options by funds: $92K

1.72% less ownership

Funds ownership: 60.57% → 58.85% (-1.7%)

5% less funds holding

Funds holding: 75 → 71 (-4)

10% less capital inflows, than outflows

Capital inflows: $10M | Capital outflows: $11.1M

21% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 24

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
71
Holders Change
-4
Holders Change %
-5.33%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
19
Reduced
24
Closed
11
Calls
$129​K
Puts
$92​K
Net Calls
+$37​K
Net Calls Change
-⁠$65​K

ISEE Hedge Fund Activity: Q1 2018 in Review

71 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio (ISEE) for Q1 2018, worth a combined $58.3M — down 14% from $68.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ISEE and 8 opened new positions — a net loss of 3 holders — while 24 trimmed existing stakes and 19 added.

The largest buyer was AJO LP, adding an estimated $1.74M. The largest seller was Stonepine Capital Management, cutting an estimated $2.19M.

  • 71 institutional investors held IVERIC bio (ISEE) as of Q1 2018, down from 75 in Q4 2017.
  • Funds reported $58.3M of IVERIC bio stock for Q1 2018, down 14% quarter-over-quarter.
  • 8 funds opened new IVERIC bio positions in Q1 2018 and 11 closed out, a net change of -3 holders.
  • The largest IVERIC bio buyer in Q1 2018 was AJO LP, an estimated $1.74M added.
  • The largest IVERIC bio seller in Q1 2018 was Stonepine Capital Management, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2018.